Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

By Baldridge J.R.   Yorgensen Y.   Ward J.R.   Ulrich J.T.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2416-2425

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity

By Yao Q.   Vuong V.   Li M.   Compans R.W.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2537-2545

Elsevier

Access to resources Recommend Favorite

Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system

By Nally  

Vaccine, Vol. 19, Iss. 4, 2000-10 ,pp. : 492-497

Elsevier

Access to resources Recommend Favorite

Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate

By Shen X.   Lagergard T.   Yang Y.   Lindblad M.   Fredriksson M.   Wallerstrom G.   Holmgren J.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3360-3368

Elsevier

Access to resources Recommend Favorite

Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation

By Siddiqui A.A.   Phillips T.   Charest H.   Podesta R.B.   Quinlin M.L.   Pinkston J.R.   Lloyd J.D.   Pompa J.   Villalovos R.M.   Paz M.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2882-2889

Elsevier

Access to resources Recommend Favorite